Vifor Pharma
56
0
0
38
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
17.9%
10 terminated/withdrawn out of 56 trials
79.2%
-7.3% vs industry average
61%
34 trials in Phase 3/4
18%
7 of 38 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (56)
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
Role: collaborator
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Role: collaborator
Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
Role: collaborator
Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
Role: lead
Hyperkalaemia and Its Impact on Therapy with RAASi
Role: collaborator
Patiromer Trial in CKD Stage IIIB to V
Role: collaborator
Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
Role: collaborator
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
Role: collaborator
Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
Role: collaborator
CKD-aP Among Adults on Dialysis in Switzerland
Role: collaborator
mHealth for Phosphorus Management in CKD.
Role: collaborator
The German Patient Blood Management Network
Role: collaborator
The Use of Iron Therapy for Patients With Anemia After Caesarean Section
Role: collaborator
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
Role: lead
Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation
Role: collaborator
Omega 3/6 Fatty Acids for Reading in Children
Role: collaborator
Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
Role: lead
Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
Role: collaborator
Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
Role: collaborator
Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
Role: collaborator